Improving functioning in veterans with OCD using therapy
Official title: Exposure and Response Prevention to Improve Functioning in Veterans With Obsessive Compulsive Disorder
Run by VA Office of Research and Development · NCT05240924 · Data updated 2026-11-12
This study is testing if a special therapy called Exposure and Response Prevention can help veterans with OCD feel better and improve their daily lives compared to a stress management program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 19 sites (East Orange, New Jersey and 18 other locations) |
| Status | Recruiting |
| Started | October 3, 2022 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT05240924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are veterans with a primary diagnosis of OCD, with or without comorbid PTSD, who are receiving care from specified VA medical centers.
✕Probably not a fit
Patients with significant cognitive impairment, current psychosis, or severe substance use issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of Exposure and Response Prevention (ERP) therapy in improving functioning, quality of life, and OCD symptoms among veterans diagnosed with OCD, including those with comorbid PTSD. Over four years, 160 veterans will be randomized to receive either ERP or a control condition of stress management training, with assessments conducted post-treatment and six months later. The study also includes a qualitative evaluation of veterans' perceptions of treatment impact and the implementation potential of ERP in VA mental health settings.
Why it matters
Potential benefit: If successful, this study could significantly enhance the quality of life and functioning of veterans suffering from OCD and PTSD.
How similar studies have gone: While ERP is a well-established treatment for OCD, this specific application among veterans with comorbid PTSD has not been extensively tested, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veterans having a primary diagnosis of Obsessive Compulsive Disorder (OCD)(50% of sample) and comorbid OCD and Post-traumatic stress disorder (PTSD) (50% of sample) who are receiving care from the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, TX; the Ralph H. Johnson VA Medical Center in Charleston, SC; the VISN 20 Clinical Resource Hub which provides telehealth services to Washington, Oregon, and Alaska: the VISN 2 Clinical Resource Hub which provides telehealth services to New Jersey, New York, and northern Pennsylvania, and the VISN 6 Clinical Resource Hub which provides telehealth services to North Carolina and Virginia. * Willingness to participate in Exposure and Response Prevention(ERP) Exclusion Criteria: * Significant cognitive impairment or conditions that threaten safety (current psychosis, mania, imminent suicidality including plan or intent, and treatment-interfering moderate to severe substance use). * Potential participants taking psychotropic medications must be on a stable dose of these medications for at least 6 weeks prior to study enrollment.
Where it's running
-
East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
East Orange, New Jersey, United States Recruiting -
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, United States Recruiting -
VA NY Harbor Healthcare System, New York, NY
New York, New York, United States Recruiting -
Northport VA Medical Center, Northport, NY
Northport, New York, United States Recruiting -
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States Recruiting -
Asheville VA Medical Center, Asheville, NC
Asheville, North Carolina, United States Recruiting
Show 13 more locations
-
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States Recruiting -
Fayetteville VA Medical Center, Fayetteville, NC
Fayetteville, North Carolina, United States Recruiting -
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Salisbury, North Carolina, United States Recruiting -
VA Roseburg Healthcare System, Roseburg, OR
Roseburg, Oregon, United States Recruiting -
VA Southern Oregon Rehabilitation Center and Clinics, White City, OR
White City, Oregon, United States Recruiting -
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States Recruiting -
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States Recruiting -
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States Recruiting -
Hampton VA Medical Center, Hampton, VA
Hampton, Virginia, United States Recruiting -
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Richmond, Virginia, United States Recruiting -
Salem VA Medical Center, Salem, VA
Salem, Virginia, United States Recruiting -
Spokane VA Medical Center, Spokane, WA
Spokane, Washington, United States Recruiting -
Jonathan M. Wainwright Memorial VA Medical Center, Walla Walla, WA
Walla Walla, Washington, United States Recruiting
Study contacts
- Principal investigator: Terri L. Fletcher, PhD — Michael E. DeBakey VA Medical Center, Houston, TX
- Study coordinator: Terri L Fletcher, PhD
- Email: Terri.Fletcher@va.gov
- Phone: (713) 440-4400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD
This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.
-
Bergen Four-Day Treatment for OCD, in Finland
This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.
-
Test different deep TMS coils and targets to treat OCD
This study tests whether different deep TMS coils and brain targets help reduce OCD symptoms in adults with OCD, using a double-blind setup with sham and active stimulation.
-
Role of theta brain waves in how kids control thoughts and actions
This study tests whether theta-frequency brain activity can reveal how children with ADHD or OCD, and healthy kids, manage thinking and behavior during tasks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.